Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Human albumin microspheres are micro- or nanoparticles composed of human albumin, primarily utilized in medical imaging as contrast agents to enhance visualization of various physiological processes. They are employed in techniques such as echocardiography, positron emission tomography (PET), and scintigraphy to assess regional blood flow, pulmonary perfusion, and cardiac function. Beyond diagnostic applications, these microspheres have also been investigated as carriers for targeted drug delivery, such as with chemotherapeutic agents like Daunomycin, and as enhancers for gene transfer in conjunction with ultrasound. Their function relies on their physical properties, including size and inertness, allowing them to distribute within the body and provide a signal for imaging or to transport therapeutic payloads.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Human albumin microspheres.